Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Compr Physiol. 2011 Jul;1(3):1603-48. doi: 10.1002/cphy.c100059.
This article is devoted to the role of genetic variation and gene-exercise interactions in the biology of adaptation to exercise. There is evidence from genetic epidemiology research that DNA sequence differences contribute to human variation in physical activity level, cardiorespiratory fitness in the untrained state, cardiovascular and metabolic response to acute exercise, and responsiveness to regular exercise. Methodological and technological advances have made it possible to undertake the molecular dissection of the genetic component of complex, multifactorial traits, such as those of interest to exercise biology, in terms of tissue expression profile, genes, and allelic variants. The evidence from animal models and human studies is considered. Data on candidate genes, genome-wide linkage results, genome-wide association findings, expression arrays, and combinations of these approaches are reviewed. Combining transcriptomic and genomic technologies has been shown to be more powerful as evidenced by the development of a recent molecular predictor of the ability to increase VO2max with exercise training. For exercise as a behavior and physiological fitness as a state to be major players in public health policies will require that the role of human individuality and the influence of DNA sequence differences be understood. Likewise, progress in the use of exercise in therapeutic medicine will depend to a large extent on our ability to identify the favorable responders for given physiological properties to a given exercise regimen.
这篇文章致力于探讨遗传变异和基因-运动相互作用在运动适应生物学中的作用。遗传流行病学研究的证据表明,DNA 序列差异导致了人类在体力活动水平、未经训练状态下的心肺健康、对急性运动的心血管和代谢反应以及对常规运动的反应等方面的个体差异。方法学和技术的进步使得人们有可能根据组织表达谱、基因和等位基因变体,对运动生物学等复杂多因素特征的遗传成分进行分子剖析。考虑了来自动物模型和人类研究的证据。对候选基因、全基因组连锁研究结果、全基因组关联研究结果、表达谱阵列以及这些方法的组合进行了综述。正如最近开发的一种能够预测通过运动训练增加最大摄氧量的分子预测器所证明的那样,结合转录组学和基因组学技术更具威力。要使运动作为一种行为和生理健康作为一种状态成为公共卫生政策的主要参与者,就需要了解人类个体的作用和 DNA 序列差异的影响。同样,在治疗医学中使用运动的进展在很大程度上取决于我们识别给定生理特性对特定运动方案的有利反应者的能力。